Mountain View, CA, United States of America

Michael Dorwart

This inventor holds 14 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 5 EPO patents. Top assignees: Roche Sequencing Solutions, Inc., Nautilus Subsidiary, Inc., Columbia University. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Dorwart. Retrieved from https://idiyas.com/inventor/michael-dorwart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

Mtn. View, CA (US) (2019)
Mountain View, CA (US) (2019 - 2024)
San Jose, CA (US) (2021 - 2024)

Company Filing History:

9 out of 299

Roche Sequencing Solutions, Inc.

patents

3 out of 29

Nautilus Subsidiary, Inc.

Genia Technologies, Inc.

patents

where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577608 - AFFINITY REAGENTS HAVING ENHANCED BINDING AND DETECTION CHARACTERISTICS (2026-03-17),

2. 12043648 - Alpha-hemolysin variants with altered characteristics (2024-07-23),

3. 11993807 - Affinity reagents having enhanced binding and detection characteristics (2024-05-28),

4. 11821034 - Nucleic acid sample preparation methods (2023-11-21),

5. 11692217 - Affinity reagents having enhanced binding and detection characteristics (2023-07-04),

6. 11674174 - Nucleic acid sequences using tags (2023-06-13),

7. 11479584 - Alpha-hemolysin variants with altered characteristics (2022-10-25),

8. 11261488 - Alpha-hemolysin variants (2022-03-01),

9. 11111534 - Nucleic acid sample preparation methods (2021-09-07),

10. 10752948 - Alpha-hemolysin variants (2020-08-25),

11. 10683331 - Alpha-hemolysin variants with altered characteristics (2020-06-16),

12. 10526647 - Nucleic acid sequences using tags (2020-01-07),

13. 10301361 - α-hemolysin variants with altered characteristics (2019-05-28),

14. 10227645 - Alpha-hemolysin variants (2019-03-12),

Title: The Innovative Journey of Michael Dorwart

Introduction: Michael Dorwart, a talented inventor based in Mountain View, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Michael Dorwart's latest patents include a cutting-edge software application for data encryption and a revolutionary device for enhancing solar energy efficiency.

Career Highlights: With over two decades of experience in the tech industry, Michael Dorwart has a proven track record of developing innovative solutions that have reshaped the way we interact with technology. His work has been recognized with multiple awards and accolades.

Collaborations: Throughout his career, Michael Dorwart has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work across disciplines has led to the creation of groundbreaking technologies that have had a lasting impact on the industry.

Conclusion: Michael Dorwart's passion for innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the field of inventions. His work continues to inspire the next generation of inventors to think outside the box and create solutions that shape the future.

Profile summary based on public USPTO records.